2024
Antithrombotic Strategies for Patients With Peripheral Artery Disease JACC Scientific Statement
Bonaca M, Barnes G, Bauersachs R, Bessada Y, Conte M, Dua A, Hess C, Serhal M, Mena-Hurtado C, Weitz J, Beckman J. Antithrombotic Strategies for Patients With Peripheral Artery Disease JACC Scientific Statement. Journal Of The American College Of Cardiology 2024, 84: 936-952. PMID: 39197984, DOI: 10.1016/j.jacc.2024.06.027.Peer-Reviewed Original ResearchConceptsPeripheral arterial diseaseAntithrombotic strategiesArtery diseaseResponse to antithrombotic therapyLimb eventsRisk of bleedingCoronary artery diseaseAdverse limb eventsAntithrombotic therapyMultidisciplinary working groupClinical scenariosPatientsAssessment of benefit-riskBenefit-riskAnticoagulationDiseaseScientific statementPatient-centeredBleeding
2020
Outcomes with catheter‐directed thrombolysis compared with anticoagulation alone in patients with acute deep venous thrombosis
Abraham B, Sedhom R, Megaly M, Saad M, Elbadawi A, Elgendy IY, Omer M, Narayanan MA, Mena‐Hurtado C, Pershad A, Shamoun F, Lalonde T, Attallah A. Outcomes with catheter‐directed thrombolysis compared with anticoagulation alone in patients with acute deep venous thrombosis. Catheterization And Cardiovascular Interventions 2020, 97: e61-e70. PMID: 32936517, DOI: 10.1002/ccd.29226.Peer-Reviewed Original ResearchConceptsAcute deep venous thrombosisCatheter-directed thrombolysisDeep venous thrombosisVenous patencyPostthrombotic syndromeVenous thrombosisManagement of DVTMajor bleedingHospital stayMean followCDT groupBlood transfusionAnticoagulationHigher oddsHigh riskLower riskPatientsSystematic reviewPatencyThromboembolismThrombolysisThrombosisSyndromeHigh rateRisk